Quality Assurance in Cancer Screening 1
Tracks
Thursday, June 19, 2025 |
10:30 - 11:45 |
Conference Room A, Comwell Aarhus, Dolce by Wyndham |
Overview
Parallel Session
Speaker(s)
Dr Patricia Fitzpatrick
Full Professor Of Epidemiology & Biomedical Statistics
University College Dublin
Consensus on calculation of interval cancer rates for cervical cancer screening? An international survey
Biography
Dr Patricia Fitzpatrick is Full Professor of Epidemiology & Biomedical Statistics & Subject Head for Public Health, University College Dublin & Consultant in Preventative Medicine, St Vincent’s University Hospital, Dublin. She is also Consultant Epidemiologist/Director of Evaluation for the National Screening Service, Ireland.
Miss Tanya Geertse
QA & Accreditation Coordinator
LRCB
Utilizing the “positive predictive value – recall diagram” for monitoring key performance indicators of groups of radiologists reading screening mammograms
Biography
Tanya D. Geertse is a PhD-student on breast cancer screening and quality assurance. With expertise in radiology and data analysis, she focuses on evaluating screening performance and developing tools for training of screening radiologists. Tanya has performed studies on the value of audits, supplemental training of screening radiologists, added value of prereading screening mammograms by radiographers and the dilemma of recalling well-circumscribed masses. She collaborates with multidisciplinary teams (epidemiology, radiology and pathology) to improve the screening performance of radiologists.
Dr Ethan Halm
Vice Chancellor For Population Health
Rutgers University Biomedical Health Sciences
Long term patterns and predictors of repeat fecal immunochemical testing for colorectal cancer screening in four regional US health systems
Biography
Ethan A. Halm, MD, MPH, MBA is a tenured Professor Medicine and the Vice Chancellor for Population Health at Rutgers University Biomedical and Health Sciences in New Jersey, USA. In this role, he aims to advance Population Health initiatives in research, education, and clinical care across the Rutgers University schools of medicine, public health, nursing, pharmacy, health professions, dentistry, and graduate studies. He is also the Deputy Chief Population Health Officer for the Robert Wood Johnson Barnabas Health System, a 12 hospital regional healthcare network that is the leading academic health system in the state of New Jersey.
Mrs Solveig Hofvind
Researcher
Cancer Registry, Norwegian Institute Of Public Health
Using the new European guidelines for breast cancer services to report on screening programme indicators in BreastScreen Norway
Biography
Hofvind is leading BreastScreen Norway, with focus on quality assurance and evidence based improvement of the program.
Ms Rableen Nagra
Operations Director, Breast & Lung Screening
BC Cancer - Vancouver, Canada
Evaluating Canada’s first province wide risk-based lung screening program
Biography
Rableen has over 12 years of operations experience in various health care settings. Her current portfolio includes managing operations for two provincial cancer screening programs – breast and lung. Previously, as a primary care manager she developed and implemented the Primary Care Networks and established the first Community Health Centre with the Ministry of Health.
Rableen has a Bachelor of Science in Biology and a Master of Arts in Healthcare Leadership.
Rableen resides in Vancouver with her husband and two sons. In her spare time, she is exploring a good cup of coffee with a park nearby for the toddlers!
Dr Ursula Ramathuba
Associate Prof
University Of Venda
Assessing the quality of the endocervical component: Pitfalls to cervical cancer screening in Limpopo province, South Africa
Biography
Dr Hanna Ribbing Wilén
Surgeon, Karolinska University Hospital
Karolinska Institutet
The effect on colorectal cancer incidence and staging with population-based FOBT-screening in Sweden
Biography
My name is Hanna Ribbing Wilén, MD, PhD. I am a general surgeon working at the emergency and trauma surgery division at Karolinska University Hospital Huddinge in Stockholm, Sweden, and researcher affiliated to Karolinska Institutet, Department of Clinical Science and Education Södersjukhuset, Stockholm, Sweden. My field of research is colorectal cancer screening strategies, fecal occult blood test, interval cancers and gender differences in screening.
Chair(s)
Muluken Gizaw
Addis Ababa University
Sisse Njor
Professor
Research Unit For Screening And Epidemiology, Lillebaelt Hospital, Vejle, Denmark Denmark
